British Sarcoma Group

Executive Office 35 Sandford Avenue Church Stretton Shropshire SY6 6BH Telephone 01694 722123

Trial Name	TRUSTS - TRABECTEDIN FIRST-LINE
Description	A Phase III study of the safety and effectiveness of two trabectedin regimes versus doxorubicin in elderly patients with unteated advanced or metastatic sarcomas.
Reference	NCT00796120 EORTC 62091 Sponsor: Pharmamar with Johnson & Johnson
Status / Sites	OPEN Manchester, Sheffield, Glasgow and Nottingham
UK Chief Investigator Contact	Dr Mike Leahy, Manchester

You are viewing the text version of this site.

To view the full version please install the Adobe Flash Player and ensure your web browser has JavaScript enabled.

Need help? check the requirements page.